🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

10x Genomics, Inc.

TXG Healthcare
$68.59 +$2.21 (3.33%)
Market Cap: $8.94 B
Gurus Holding
9
Popularity Rank
#716
% of Shares Held
11.73%
Net Activity (Q2 2026)
-$8.85 M

Guru Ownership Trend

Guru Analysis for 10x Genomics, Inc. (TXG)

10x Genomics, Inc. (TXG), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.05 B.

Top institutional holders include Catherine Wood and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $8.85 M net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Ray Dalio reduced exposure by 61.9%.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$86.49 M
Total Buy Value
New Buys 2
Additions 0
-$95.34 M
Total Sell Value
Reductions 7
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
7
Net Buyers
2

FAQs for 10x Genomics, Inc. (TXG)

Major holders include Catherine Wood ($383.52 M), Cliff Asness ($74.7 M), Steven Cohen ($71.04 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 15.28 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $8.85 M, with 2 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 7 managers trimmed their positions, while 0 fully exited TXG. The total reported sell value was $95.34 M.

Yes, 2 managers opened new positions in TXG, and 0 increased their existing holdings. The total reported buy value was $86.49 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
2.49% Reduce -14.6% 10,003,057 $383.52 M Q2 2026
0.03% Reduce -20.2% 2,026,464 $74.7 M Q2 2026
0.08% New Buy 1,852,776 $71.04 M Q2 2026
0.04% Reduce -20.5% 802,039 $30.75 M Q2 2026
0.30% New Buy 403,100 $15.46 M Q2 2026
0.01% Reduce -3.7% 110,660 $4.24 M Q2 2026
0.37% Reduce -33.3% 42,000 $1.61 M Q2 2026
0.01% Reduce -48.0% 29,000 $1.11 M Q2 2026
0.00% Reduce -61.9% 13,375 $512,798 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form